“Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
“Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-24
DOI
10.3389/fonc.2020.627701
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coenzyme Q10 attenuates rat hepatocarcinogenesis via the reduction of CD59 expression and phospholipase D activity
- (2020) Mahmoud Abdel‐Latif et al. CELL BIOCHEMISTRY AND FUNCTION
- Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development
- (2020) Arthur T. Kopylov et al. MOLECULES
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver
- (2020) Tung-Ching Ho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma
- (2020) Long Pan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Activated Hepatic Stellate Cells (HSCs) Exert Immunosuppressive Effects in Hepatocellular Carcinoma by Producing Complement C3
- (2020) Yaping Xu et al. OncoTargets and Therapy
- The future of cancer immunotherapy: microenvironment-targeting combinations
- (2020) Yonina R. Murciano-Goroff et al. CELL RESEARCH
- Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials
- (2020) Choudhary Harsha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
- (2020) Chongxian Pan et al. Journal of Hematology & Oncology
- Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus
- (2020) Zhe Li et al. MEDICINE
- Immune-based therapies for hepatocellular carcinoma
- (2020) David J. Pinato et al. ONCOGENE
- Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma
- (2020) Feng Xue et al. PeerJ
- The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
- (2020) Alireza Labani-Motlagh et al. Frontiers in Immunology
- Clinical Features of COVID-19-Related Liver Functional Abnormality
- (2020) Zhenyu Fan et al. Clinical Gastroenterology and Hepatology
- Immune Checkpoint Inhibitors in Hepatocellular Cancer: Current Understanding on Mechanisms of Resistance and Biomarkers of Response to Treatment
- (2020) Amblessed E. Onuma et al. GENE EXPRESSION
- Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases
- (2020) Maria K. Skytthe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Complement factor H–deficient mice develop spontaneous hepatic tumors
- (2020) Jennifer Laskowski et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma
- (2020) Gang Ning et al. Biomed Research International
- Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study
- (2020) Donghee Kim et al. Clinical Gastroenterology and Hepatology
- A genetic variant in the promoter of CD46 is associated with the risk and prognosis of hepatocellular carcinoma
- (2020) Fei Liu et al. MOLECULAR CARCINOGENESIS
- Identification of the Sixth Complement Component as Potential Key Genes in Hepatocellular Carcinoma via Bioinformatics Analysis
- (2020) Di Mu et al. Biomed Research International
- The role of complement in liver injury, regeneration and transplantation
- (2019) Ebbe Billmann Thorgersen et al. HEPATOLOGY
- Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
- (2019) Yoon Yang et al. SEMINARS IN LIVER DISEASE
- Downregulated expression of CFHL1 is associated with unfavorable prognosis in postoperative patients with hepatocellular carcinoma
- (2019) Hao Feng et al. Experimental and Therapeutic Medicine
- Treatment Strategies for Hepatocellular Carcinoma – a Multidisciplinary Approach
- (2019) Isabella Lurje et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Positive Feedback Loop Between Cancer Stem‐Like Cells and Tumor‐Associated Neutrophils Controls Hepatocellular Carcinoma Progression
- (2019) Shao‐Lai Zhou et al. HEPATOLOGY
- Elevated serum activity of MBL and ficolin-2 as biomarkers for progression to hepatocellular carcinoma in chronic HCV infection
- (2019) Paywast J. Jalal et al. VIROLOGY
- Complement factor H‑related 3 overexpression affects hepatocellular carcinoma proliferation and apoptosis
- (2019) Hong Liu et al. Molecular Medicine Reports
- Complement in Metastasis: A Comp in the Camp
- (2019) Daniel Ajona et al. Frontiers in Immunology
- Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression
- (2019) Antonino Bruno et al. Frontiers in Immunology
- Current Treatment Landscape for Advanced Hepatocellular Carcinoma: Patient Outcomes and the Impact on Quality of Life
- (2019) Daneng Li et al. Cancers
- Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers
- (2019) Flavia Fondevila et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
- (2019) Chen Lu et al. Molecular Cancer
- microRNA-17 functions as an oncogene by downregulating Smad3 expression in hepatocellular carcinoma
- (2019) Zhufeng Lu et al. Cell Death & Disease
- Macrophages and hepatocellular carcinoma
- (2019) Zhiqiang Tian et al. Cell and Bioscience
- Role of the complement system in the tumor microenvironment
- (2019) Ronghua Zhang et al. Cancer Cell International
- CFHR3 is a potential novel biomarker for hepatocellular carcinoma
- (2019) Jun Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
- (2019) Spencer C. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complement Receptor 1 (CR1, CD35) Polymorphisms and Soluble CR1: A Proposed Anti-inflammatory Role to Quench the Fire of “Fogo Selvagem” Pemphigus Foliaceus
- (2019) Luana Caroline Oliveira et al. Frontiers in Immunology
- Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches
- (2019) Maria Tagliamonte et al. CANCER LETTERS
- Should MASP-2 Deficiency Be Considered a Primary Immunodeficiency? Relevance of the Lectin Pathway
- (2019) M. Isabel García-Laorden et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Associations between twelve common gene polymorphisms and susceptibility to hepatocellular carcinoma: evidence from a meta-analysis
- (2019) Yi Quan et al. World Journal of Surgical Oncology
- Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects
- (2018) Daniel Ajona et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer
- (2018) Chunmei Piao et al. EXPERIMENTAL CELL RESEARCH
- Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience
- (2018) Riad Salem et al. HEPATOLOGY
- Binding of Free and Immune Complex-Associated Hepatitis C Virus to Erythrocytes Is Mediated by the Complement System
- (2018) Kazi Abdus Salam et al. HEPATOLOGY
- Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment
- (2018) Jingying Zhang et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Genetic association of complement component 2 variants with chronic hepatitis B in a Korean population
- (2018) Suhg Namgoong et al. LIVER INTERNATIONAL
- IL-17A promotes the invasion-metastasis cascade via the AKT pathway in hepatocellular carcinoma
- (2018) Qing-guo Xu et al. Molecular Oncology
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatitis B virus inhibits the expression of complement C3 and C4, in�vitro and in�vivo
- (2018) Chengliang Zhu et al. Oncology Letters
- Complement C1q stimulates the progression of hepatocellular tumor through the activation of discoidin domain receptor 1
- (2018) Ji-Hyun Lee et al. Scientific Reports
- IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction
- (2018) Nicholas J. W. Easom et al. Frontiers in Immunology
- Complementing Cancer Metastasis
- (2018) Dawn M. Kochanek et al. Frontiers in Immunology
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016
- (2018) et al. JAMA Oncology
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Interleukin-1 Beta—A Friend or Foe in Malignancies?
- (2018) Rebekka Bent et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
- (2018) Christopher Groth et al. BRITISH JOURNAL OF CANCER
- Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy
- (2018) Terry R. Medler et al. CANCER CELL
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages
- (2018) Haoran Zha et al. Cancer Immunology Research
- MASP-1 and MASP-2 Serum Levels Are Associated With Worse Prognostic in Cervical Cancer Progression
- (2018) Carlos Afonso Maestri et al. Frontiers in Immunology
- Innate Immune Cells in Immune Tolerance After Liver Transplantation
- (2018) Hongting Huang et al. Frontiers in Immunology
- Mannan-binding lectin suppresses growth of hepatocellular carcinoma by regulating hepatic stellate cell activation via the ERK/COX-2/PGE2 pathway
- (2018) Junru Li et al. OncoImmunology
- Genetic polymorphisms in complement receptor 1 gene and its association with HBV-related liver disease: A case-control study
- (2018) Jingrong Luo et al. GENE
- Circulating CD14+ HLA-DR−/low myeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery
- (2017) Xing-Hui Gao et al. HEPATOLOGY RESEARCH
- The complement system in cancer: Ambivalence between tumour destruction and promotion
- (2017) Srinivas Mamidi et al. IMMUNOBIOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
- (2017) Wenxia Shi et al. MEDICINE
- Profiling, clinicopathological correlation and functional validation of specific long non-coding RNAs for hepatocellular carcinoma
- (2017) Jian Yao et al. Molecular Cancer
- Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment
- (2017) Daniel Ajona et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- A molecular and preclinical comparison of the PD-1–targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab
- (2017) Petros Fessas et al. SEMINARS IN ONCOLOGY
- Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma
- (2017) Ze-Wu Meng et al. TUMOR BIOLOGY
- G2/M checkpoint plays a vital role at the early stage of HCC by analysis of key pathways and genes
- (2017) Li Yin et al. Oncotarget
- Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD)
- (2017) Zoltan Czigany et al. BMJ Open
- A Serum Protein Signature Associated with Outcome after Anti–PD-1 Therapy in Metastatic Melanoma
- (2017) Jeffrey S. Weber et al. Cancer Immunology Research
- C5a Regulates IL-1β Production and Leukocyte Recruitment in a Murine Model of Monosodium Urate Crystal-Induced Peritonitis
- (2017) Hanif J. Khameneh et al. Frontiers in Pharmacology
- Coagulation factor levels in non-metastatic colorectal cancer patients
- (2017) S. Battistelli et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
- Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
- (2016) Yi-Peng Fu et al. BRITISH JOURNAL OF CANCER
- Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1
- (2016) Hyang Sook Seol et al. CANCER LETTERS
- C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial–mesenchymal transition
- (2016) Wen-Hao Hu et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
- (2016) Shao-Lai Zhou et al. GASTROENTEROLOGY
- Mannose-binding lectin 2 rs11003123 polymorphism is associated with the development of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis in the Chinese population
- (2016) Pu-Sen Wang et al. Hepatobiliary & Pancreatic Diseases International
- Complement-Mediated Regulation of Metabolism and Basic Cellular Processes
- (2016) Christoph Hess et al. IMMUNITY
- Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells
- (2016) Daniel W. Sherbenou et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomes
- (2016) Hidetoshi Nitta et al. MEDICAL ONCOLOGY
- C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation
- (2016) Roberta Bulla et al. Nature Communications
- Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis
- (2016) Silvia Guglietta et al. Nature Communications
- Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression
- (2016) Y. Wang et al. Cancer Discovery
- Genetic variants of mannose-binding lectin 2 gene influence progression and prognosis of patients with hepatitis B virus infection in China
- (2016) Xing Gu et al. Clinics and Research in Hepatology and Gastroenterology
- IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling
- (2016) Rui Liu et al. Oncotarget
- Hepatitis B virus X protein up-regulates C4b-binding protein α through activating transcription factor Sp1 in protection of hepatoma cells from complement attack
- (2016) Guoxing Feng et al. Oncotarget
- Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2
- (2016) Yaping Xu et al. Oncotarget
- Elevated serum complement factors 3 and 4 are strong inflammatory markers of the metabolic syndrome development: a longitudinal cohort study
- (2016) Zhenfang Liu et al. Scientific Reports
- Association between mannose-binding lectin variants, haplotypes and risk of hepatocellular carcinoma: A case-control study
- (2016) Chenghao Su et al. Scientific Reports
- Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions
- (2016) Jonathan P. Hannan et al. PLoS One
- CXCR2/CXCL5 axis contributes to epithelial–mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling
- (2015) Shao-Lai Zhou et al. CANCER LETTERS
- Fully-sialylated alpha-chain of complement 4-binding protein: Diagnostic utility for ovarian clear cell carcinoma
- (2015) Mikio Mikami et al. GYNECOLOGIC ONCOLOGY
- Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis
- (2015) Oihane García-Irigoyen et al. HEPATOLOGY
- Tumor-infiltrating, interleukin-33-producing effector-memory CD8+T cells in resected hepatocellular carcinoma prolong patient survival
- (2015) Stefan M. Brunner et al. HEPATOLOGY
- Myeloid cells in hepatocellular carcinoma
- (2015) Shanshan Wan et al. HEPATOLOGY
- Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration
- (2015) Chunmei Piao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immunity, inflammation, and cancer: an eternal fight between good and evil
- (2015) Shabnam Shalapour et al. JOURNAL OF CLINICAL INVESTIGATION
- Complement Inhibition Prevents Oncolytic Vaccinia Virus Neutralization in Immune Humans and Cynomolgus Macaques
- (2015) Laura Evgin et al. MOLECULAR THERAPY
- Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial–mesenchymal transition
- (2015) M T Goswami et al. ONCOGENE
- Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis
- (2015) Gustavo Ferrín et al. PLoS One
- Downregulation of matrix metalloproteinases contributes to the inhibition of cell migration and invasion in HepG2 cells by sodium valproate
- (2015) XIA ZHAO et al. Oncology Letters
- Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells
- (2015) Chun-Hui Yuan et al. Oncotarget
- Hepatocellular Carcinoma
- (2015) M.-A. Buendia et al. Cold Spring Harbor Perspectives in Medicine
- The evolving epidemiology of hepatocellular carcinoma: a global perspective
- (2015) Michael C Wallace et al. Expert Review of Gastroenterology & Hepatology
- Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach
- (2015) Faryal Mehwish Awan et al. PLoS One
- Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumours
- (2014) Anna St. Swierzko et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL-17A Produced by T Cells Promotes Tumor Growth in Hepatocellular Carcinoma
- (2014) S. Ma et al. CANCER RESEARCH
- Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche
- (2014) S. K. Vadrevu et al. CANCER RESEARCH
- The Complement Inhibitor CD59 Regulates Insulin Secretion by Modulating Exocytotic Events
- (2014) Ulrika Krus et al. Cell Metabolism
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
- (2014) Shanshan Wan et al. GASTROENTEROLOGY
- CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
- (2014) Josef Ehling et al. GUT
- Endothelial progenitors promote hepatocarcinoma intrahepatic metastasis through monocyte chemotactic protein-1 induction of microRNA-21
- (2014) Yu-Tsung Shih et al. GUT
- Emerging trends in hepatocellular carcinoma incidence and mortality
- (2014) Basile Njei et al. HEPATOLOGY
- Hyper-IL-15 suppresses metastatic and autochthonous liver cancer by promoting tumour-specific CD8+ T cell responses
- (2014) Liang Cheng et al. JOURNAL OF HEPATOLOGY
- Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation
- (2014) Kenneth S. H. Chok et al. LIVER TRANSPLANTATION
- Increased CD59 protein expression is associated with the outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP
- (2014) Guoqi Song et al. MEDICAL ONCOLOGY
- The SDF-1/CXCR4 axis induces epithelial–mesenchymal transition in hepatocellular carcinoma
- (2014) Xuqi Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Metadata Checklist: Identification of CHI3L1 and MASP2 as a Biomarker Pair for Liver Cancer Through Integrative Secretome and Transcriptome Analysis
- (2014) Wenchao Ding et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Roles of Tregs in development of hepatocellular carcinoma: A meta-analysis
- (2014) Hong-Qiang Zhao WORLD JOURNAL OF GASTROENTEROLOGY
- Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells
- (2014) Jing-Jing Zhao et al. Scientific Reports
- Circulating AIM Prevents Hepatocellular Carcinoma through Complement Activation
- (2014) Natsumi Maehara et al. Cell Reports
- The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon
- (2014) John Meletis MEDICAL SCIENCE MONITOR
- Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
- (2013) Tania M Welzel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells
- (2013) C.-C. Hsieh et al. BLOOD
- Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma
- (2013) Qiu-Zhong Pan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hepatitis B virus X protein protects hepatoma and hepatic cells from complement-dependent cytotoxicity by up-regulation of CD46
- (2013) Shuai Zhang et al. FEBS LETTERS
- Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells
- (2013) Esther Bertran et al. HEPATOLOGY
- Intracellular Complement Activation Sustains T Cell Homeostasis and Mediates Effector Differentiation
- (2013) M. Kathryn Liszewski et al. IMMUNITY
- The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment
- (2013) Peixin Huang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Deciphering Complement Receptor Type 1 Interactions with Recognition Proteins of the Lectin Complement Pathway
- (2013) M. Jacquet et al. JOURNAL OF IMMUNOLOGY
- Increased serum complement C3 and C4 concentrations and their relation to severity of chronic spontaneous urticaria and CRP concentration
- (2013) Alicja Kasperska-Zajac et al. Journal of Inflammation-London
- Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres
- (2013) Nora Cazzagon et al. LIVER INTERNATIONAL
- Bioinformatic analysis of the membrane cofactor protein CD46 and microRNA expression in hepatocellular carcinoma
- (2013) ZEJUN LU et al. ONCOLOGY REPORTS
- Development of Biomarkers for Screening Hepatocellular Carcinoma Using Global Data Mining and Multiple Reaction Monitoring
- (2013) Hyunsoo Kim et al. PLoS One
- Association between Mannose-Binding Lectin Gene Polymorphisms and Hepatitis B Virus Infection: A Meta-Analysis
- (2013) Hang-di Xu et al. PLoS One
- Oncolytic and Immunotherapeutic Vaccinia Induces Antibody-Mediated Complement-Dependent Cancer Cell Lysis in Humans
- (2013) M. K. Kim et al. Science Translational Medicine
- Complement inhibition in cancer therapy
- (2013) Ruben Pio et al. SEMINARS IN IMMUNOLOGY
- Activity of mannose-binding lectin in centenarians
- (2012) Rossella Tomaiuolo et al. AGING CELL
- Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma
- (2012) Keisuke Kohga et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-Infiltrating FoxP3+ Tregs and CD8+ T Cells Affect the Prognosis of Hepatocellular Carcinoma Patients
- (2012) Yong Huang et al. DIGESTION
- Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma
- (2012) Shao-Lai Zhou et al. HEPATOLOGY
- Impairment of CD4+cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma
- (2012) Junliang Fu et al. HEPATOLOGY
- Natural killer cells in liver disease
- (2012) Zhigang Tian et al. HEPATOLOGY
- Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
- (2012) Brian F. Zamarron et al. International Journal of Biological Sciences
- OV6+ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma
- (2012) Wen Yang et al. JOURNAL OF HEPATOLOGY
- Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
- (2012) Leticia Corrales et al. JOURNAL OF IMMUNOLOGY
- Wavelet feature extraction and genetic algorithm for biomarker detection in colorectal cancer data
- (2012) Yihui Liu et al. KNOWLEDGE-BASED SYSTEMS
- Mannan-binding lectin in malignancy
- (2012) Anna S. Swierzko et al. MOLECULAR IMMUNOLOGY
- The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma
- (2012) JIANG LI et al. ONCOLOGY REPORTS
- Shotgun and targeted proteomics reveal that pre-surgery serum levels of LRG1, SAA, and C4BP may refine prognosis of resected squamous cell lung cancer
- (2012) Yan-Sheng Liu et al. Journal of Molecular Cell Biology
- Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma
- (2011) Wei Chen et al. CANCER LETTERS
- Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack
- (2011) Changliang Shan et al. CARCINOGENESIS
- Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
- (2011) Christer Baeck et al. GUT
- Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3
- (2011) Runqiu Jiang et al. HEPATOLOGY
- MASP2 gene polymorphism is associated with susceptibility to hepatitis C virus infection
- (2011) Siumara Tulio et al. HUMAN IMMUNOLOGY
- Cell-surface Receptor for Complement Component C1q (gC1qR) Is a Key Regulator for Lamellipodia Formation and Cancer Metastasis
- (2011) Ki-Bum Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genes Associated with Recurrence of Hepatocellular Carcinoma: Integrated Analysis by Gene Expression and Methylation Profiling
- (2011) Ju Dong Yang et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer
- (2011) Xiaoyang Luo et al. Journal of Proteomics
- Transcriptional Repression of C4 Complement by Hepatitis C Virus Proteins
- (2011) A. Banerjee et al. JOURNAL OF VIROLOGY
- IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma
- (2011) Fang-Ming Gu et al. Molecular Cancer
- Interleukin 17A Promotes Hepatocellular Carcinoma Metastasis via NF-kB Induced Matrix Metalloproteinases 2 and 9 Expression
- (2011) Jian Li et al. PLoS One
- Principles of and Advances in Percutaneous Ablation
- (2011) Muneeb Ahmed et al. RADIOLOGY
- Local-Regional Treatment of Hepatocellular Carcinoma
- (2011) Riccardo Lencioni et al. RADIOLOGY
- Mannan-binding lectin (MBL) and MBL-associated serine protease-2 in children with cancer
- (2011) UP Fisch et al. SWISS MEDICAL WEEKLY
- CD46 Expression is an Unfavorable Prognostic Factor in Breast Cancer Cases
- (2011) Adam Maciejczyk et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis
- (2010) I. Kourtzelis et al. BLOOD
- Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2
- (2010) Yefei Rong et al. BMC GASTROENTEROLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation
- (2010) Guobin He et al. CANCER CELL
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Roles of Chemokine Receptor 4 (CXCR4) and Chemokine Ligand 12 (CXCL12) in Metastasis of Hepatocellular Carcinoma Cells
- (2010) Hui Liu et al. Cellular & Molecular Immunology
- Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro
- (2010) N. Geis et al. CURRENT CANCER DRUG TARGETS
- Oxidative stress, inflammation, and cancer: How are they linked?
- (2010) Simone Reuter et al. FREE RADICAL BIOLOGY AND MEDICINE
- Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma
- (2010) Robert J. Clifford et al. HEPATOLOGY
- Treatment of Hepatocellular Carcinoma with Adeno-Associated Virus Encoding Interleukin-15 Superagonist
- (2010) Chia-Ming Chang et al. HUMAN GENE THERAPY
- The complement cascade as a mediator of tissue growth and regeneration
- (2010) Martin J. Rutkowski et al. INFLAMMATION RESEARCH
- A Defect of CD4+CD25+Regulatory T Cells in Inducing Interleukin-10 Production From CD4+T Cells Under CD46 Costimulation in Asthma Patients
- (2010) Ya-Qing Xu et al. JOURNAL OF ASTHMA
- Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma
- (2010) Dong-Ming Kuang et al. JOURNAL OF HEPATOLOGY
- MBL2 and MASP2 gene polymorphisms in patients with hepatocellular carcinoma
- (2010) L. Segat et al. JOURNAL OF VIRAL HEPATITIS
- Cancer and the Complement Cascade
- (2010) M. J. Rutkowski et al. MOLECULAR CANCER RESEARCH
- Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells
- (2010) John Cardone et al. NATURE IMMUNOLOGY
- IL-35-mediated induction of a potent regulatory T cell population
- (2010) Lauren W Collison et al. NATURE IMMUNOLOGY
- Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma
- (2010) B. K. Yoo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mannan-Binding Lectin (MBL) and MBL-Associated Serine Protease 2 (MASP-2) Genotypes in Colorectal Cancer
- (2010) H. Ytting et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Platelet-associated complement factor H in healthy persons and patients with atypical HUS
- (2009) C. Licht et al. BLOOD
- Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation
- (2009) S. Heinen et al. BLOOD
- Anti-CD20 monoclonal antibodies: historical and future perspectives
- (2009) S. H. Lim et al. HAEMATOLOGICA
- Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria
- (2009) Guillermo J. Ruiz-Delgado et al. Hematology
- CCR1 and CCR5 promote hepatic fibrosis in mice
- (2009) Ekihiro Seki et al. JOURNAL OF CLINICAL INVESTIGATION
- Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
- (2009) Dong-Ming Kuang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma
- (2009) Shuji Kanmura et al. JOURNAL OF GASTROENTEROLOGY
- Functions of C5a receptors
- (2009) Peter A. Ward JOURNAL OF MOLECULAR MEDICINE-JMM
- Cell Characterization by Proteome Profiling Applied to Primary Hepatocytes and Hepatocyte Cell Lines Hep-G2 and Hep-3B
- (2009) Astrid Slany et al. JOURNAL OF PROTEOME RESEARCH
- Prognosis in pediatric hematologic malignancies is associated with serum concentration of mannose-binding lectin-associated serine protease-2 (MASP-2)
- (2009) Aina Zehnder et al. PEDIATRIC BLOOD & CANCER
- Complement C1q Activates Tumor Suppressor WWOX to Induce Apoptosis in Prostate Cancer Cells
- (2009) Qunying Hong et al. PLoS One
- Complement in multiple sclerosis: its role in disease and potential as a biomarker
- (2008) G. Ingram et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
- (2008) Lun Cai et al. CLINICAL IMMUNOLOGY
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia
- (2008) HEPATOLOGY
- Pre- and postoperative levels in serum of mannan-binding lectin associated serine protease-2 —a prognostic marker in colorectal cancer
- (2008) Henriette Ytting et al. HUMAN IMMUNOLOGY
- CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NFκB through the CBM (Carma3/Bcl10/Malt1) Complex
- (2008) Daniel Martin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Complement Receptor 1: Disease associations and therapeutic implications
- (2008) Rohan Khera et al. MOLECULAR IMMUNOLOGY
- Modulation of the antitumor immune response by complement
- (2008) Maciej M Markiewski et al. NATURE IMMUNOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
- (2008) Yujin Hoshida et al. NEW ENGLAND JOURNAL OF MEDICINE
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
- Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors
- (2007) Marcin Okroj et al. MOLECULAR IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search